Some fintech companies can continue to thrive near-term, even as economic growth slows, Wells Fargo analysts say. Read More...
Motley Fool
What’s Next for Teladoc Stock?
After the dramatic collapse of its shares in late April, spurred by higher-than-expected losses, Teladoc Health (NYSE: TDOC) is down by more than 66% year to date. Likewise, Teladoc’s latest earnings update is painting a picture of an increasingly unprofitable business, where growth is always just over the horizon. To do that, it contracts healthcare providers, who then get reimbursed by the company after it collects regular subscription fees and often access fees from customers.
Add Comment